Korean J Med.  2004 Nov;67(Suppl 3):S781-S787.

A case of surgical treatment after steroid therapy for early onset sclerosing encapsulating peritonitis in patient undergoing continuous ambulatory peritoneal dialysis (CAPD)

• Lee YM
• Jung SW
• Seo GS
• Baek SH
• Ahn SH
• Song JH
• Park WC

Abstract

Sclerosing encapsulating peritonitis (SEP) is the peritoneal thickness including the state of peritoneal fibrosis resulting from peritoneal inflammatory process of multifactorial etiologies. The symptoms and signs related to SEP include anorexia, nausea, vomiting, diarrhea, constipation, abdominal distension, fever, weight loss, abdominal pain and partial or intermittent bowel obstruction resulting from disturbance of the intestinal motility by the peritoneal sclerosis. The choice of management is considered as conservative treatment. However, if surgical intervention is necessary, the prognosis after surgery is usually poor. Recently, a few reports have suggested that immunosuppression (cyclophosphamide, azathioprine (100~125 mg), colchicine) and/or corticosteroid (30~50 mg) therapy might be effective in the treatment of SEP. We report a case of SEP that developed earlier than previous reported cases in patient undergoing continuous ambulatory peritoneal dialysis (CAPD) and report the surgical treatment of SEP which responded to steroid therapy thereafter symptoms by mechanical ileus were recurred.

Keyword

Sclerosing encapsulating peritonitis; Peritoneal dialysis

MeSH Terms

Abdominal Pain
Anorexia
Azathioprine
Constipation
Diarrhea
Fever
Gastrointestinal Motility
Humans
Ileus
Immunosuppression
Nausea
Peritoneal Dialysis
Peritoneal Dialysis, Continuous Ambulatory*
Peritoneal Fibrosis
Peritonitis*
Prognosis
Vomiting
Weight Loss
Azathioprine